Rate My Professor Lauren May

May's scholarly impact is evidenced by over 6,000 citations on Google Scholar in the field of pharmacology. Key publications include 'Structure-based discovery of positive allosteric modulators of the A1 adenosine receptor' (2025), 'Molecular basis of ligand binding and receptor activation at the human A3 adenosine receptor' (2025), 'Large language models for scientific discovery in molecular property prediction' (2025, 50 citations), 'Biased receptor signalling and intracellular trafficking profiles of structurally distinct formylpeptide receptor 2 agonists' (2024), and 'Development of Putative Bivalent Dicovalent Ligands for the Adenosine A1 Receptor' (2024). She co-developed PSICHIC, an AI tool for rapid drug discovery using physicochemical graph neural networks (2024). May holds editorial positions including board member for npj Drug Discovery (2024-present), Journal of Pharmacology and Experimental Therapeutics (2022-2025), and Associate Editor for Purinergic Signalling (2022-present), as well as Guest Editor for the British Journal of Pharmacology (2024). She also serves as a peer reviewer for the NHMRC Ideas Grant Review Panel (2024). Her contributions advance GPCR pharmacology and precision medicine in cardiovascular and neurological disorders.